HeartBeam, Inc.(BEAT)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
BEAT Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for HeartBeam, Inc. (BEAT), a Healthcare sector company. BEAT is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (Q2 2026), HeartBeam, Inc. reports net income of $-5.0M, free cash flow of $-3.6M. Top institutional holders of BEAT by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, BlackRock, CORSAIR CAPITAL MANAGEMENT, L.P., based on the most recent SEC filings. BEAT trades on the Nasdaq exchange and files with the SEC under CIK 1779372. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BEAT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for HeartBeam, Inc. directly from SEC EDGAR.
Net Income
Q2 2026
$-5.0M
Free Cash Flow
Q2 2026
$-3.6M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProNet Income
-8.1% YoYOperating Income
-6.3% YoYEPS (Diluted)
+15.1% YoYTotal Assets
+78.4% YoYOp. Cash Flow
+3.3% YoYFree Cash Flow
+0.6% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Net Income | $-21.0M -8.1% | $-19.4M -32.9% | $-14.6M -12.9% | $-13.0M -192.7% | $-4.4M -314.6% | $-1.1M |
| Operating Income | $-21.1M -6.3% | $-19.9M -29.9% | $-15.3M -17.5% | $-13.0M -470.3% | $-2.3M -190.0% | $-788.0K |
| EPS (Diluted) | $-0.62 +15.1% | $-0.73 -1.4% | $-0.72 +54.7% | $-1.59 -54.4% | $-1.03 -255.2% | $-0.29 |
| Total Assets | $5.8M +78.4% | $3.3M -80.9% | $17.1M +324.1% | $4.0M -71.1% | $14.0M +27347.1% | $51.0K |
| Operating Cash Flow | $-14.0M +3.3% | $-14.5M -19.7% | $-12.1M -21.6% | $-9.9M -208.0% | $-3.2M -438.3% | $-600.0K |
| Free Cash Flow | $-14.6M +0.6% | $-14.7M -18.8% | $-12.3M -24.1% | $-9.9M | — | — |
Get alerted when BEAT's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for HeartBeam, Inc. including:
Top Institutional Holders of BEAT
VANGUARD CAPITAL MANAGEMENT LLC
$1.6M2,137,512 shBlackRock, Inc.
$740.9K987,837 shCORSAIR CAPITAL MANAGEMENT, L.P.
$684.4K912,500 shBleichroeder LP
$468.8K625,000 shGEODE CAPITAL MANAGEMENT, LLC
$359.6K479,386 shSmith, Salley & Associates
$275.7K367,647 shUBS Group AG
$224.2K298,917 shVANGUARD FIDUCIARY TRUST CO
$206.1K274,818 shSigma Planning Corp
$185.8K247,700 shBeacon Pointe Advisors, LLC
$185.3K247,058 sh
| Fund | Value | Shares |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1.6M | 2,137,512 |
| BlackRock, Inc. | $740.9K | 987,837 |
| CORSAIR CAPITAL MANAGEMENT, L.P. | $684.4K | 912,500 |
| Bleichroeder LP | $468.8K | 625,000 |
| GEODE CAPITAL MANAGEMENT, LLC | $359.6K | 479,386 |
| Smith, Salley & Associates | $275.7K | 367,647 |
| UBS Group AG | $224.2K | 298,917 |
| VANGUARD FIDUCIARY TRUST CO | $206.1K | 274,818 |
| Sigma Planning Corp | $185.8K | 247,700 |
| Beacon Pointe Advisors, LLC | $185.3K | 247,058 |
More Healthcare Companies
View all Healthcare →Put BEAT on your watchlist
Track score changes the day HeartBeam, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is BEAT a good stock to buy?
13F Pro's AI-powered analysis of HeartBeam, Inc. (BEAT) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for BEAT are available on the BEAT stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. BEAT is classified as a small company.
Which hedge funds own BEAT?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling BEAT. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of HeartBeam, Inc.'s investment landscape.